Nothing to disclose on Cipla stake buy report, says Torrent Pharma
Advertisement
Bengaluru: India's Torrent Pharmaceuticals on Friday said it has no information requiring disclosure under listing regulations, after the Economic Times reported that it was in talks to buyout the stake of rival Cipla's top shareholders.
Torrent said it "did not comment on speculative reports in the absence of verified data," and that it was not in a position to comment on the movement in its share price.
Torrent Pharma is interested in buying out top shareholder Hamied family's 33.47 per cent stake in Cipla and is trying to put together financing for the purchase, ET reported.
The company has reached out to private equity firms including Advent International, Bain Capital, Warburg Pincus and CVC Capital, for a minority stake in a consortium, the ET report said.
Additionally, it is also in talks with foreign banks such as Standard Chartered and JP Morgan for acquisition financing, and domestic shadow banks and mutual funds in share-backed promoter financing, the report added.
Cipla, which makes anti-allergic drug Cetirizine and generic versions of respiratory drugs Advair and Albuterol, had in July issued a clarification saying there is no information to disclose as per listing regulations regarding a stake sale
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.